Manufacturing company IDEX (NYSE: IEX) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 10.1% year on year to $878.7 million. On the other hand, next quarter’s revenue guidance of $871.5 million was less impressive, coming in 2% below analysts’ estimates. Its non-GAAP profit of $2.03 per share was 5.2% above analysts’ consensus estimates.

Is now the time to buy IEX? Find out in our full research report (it’s free for active Edge members).

StockStory’s Take

IDEX’s third quarter was marked by solid execution and strong organic growth, leading to a positive market reaction. Management highlighted that momentum in Health & Science Technologies (HST), along with robust demand from data centers, municipal water, and pharma, were key drivers this quarter. CEO Eric Ashleman credited the company’s “8020 philosophy” for enabling operational improvements and rapid integration of recent acquisitions, while noting that recent efforts in the Material Science Solutions platform and intelligent water businesses contributed meaningfully to performance.

Looking ahead, IDEX’s cautious guidance reflects ongoing macroeconomic uncertainty and limited visibility in some end markets. Management cited delays in large customer orders and persistent funding disruptions in fire and safety, prompting a focus on cost containment and selective investment in bolt-on acquisitions. CFO Akhil Mahendra noted, “While order activity was strong, much was received and shipped within the quarter, leaving overall backlog levels relatively flat,” suggesting that visibility remains limited as IDEX enters the fourth quarter and plans for 2026.

Key Insights from Management’s Remarks

Management pointed to targeted growth markets, portfolio optimization, and operational discipline as the primary drivers behind third quarter outperformance and strategic focus for the remainder of the year.

• Health & Science Technologies momentum: HST delivered double-digit revenue growth, fueled by strong demand in data centers, pharma, space and defense, and life sciences. Management highlighted the successful integration of recently acquired Micro-Lam, which enhanced capabilities in optics and material shaping applications.
• Intelligent Water platform gains: The municipal water business, bolstered by acquisitions like Nexsight and Subterra, was a standout, with high single-digit revenue growth. Management emphasized the increasing role of software and analytics in providing deeper insights for municipal customers.
• Material Science Solutions platform optimization: The Muon business, part of the Material Science Solutions group, improved profitability through targeted cost reductions and a shift toward higher-value commercial opportunities, especially in data center cooling and optical switching.
• Pricing execution and cost containment: IDEX benefited from robust price realization across segments, especially in response to tariff changes. Platform optimization and cost containment efforts yielded $17 million in quarterly savings, with a goal of over $60 million for the year.
• Selective capital allocation: Management reiterated a near-term focus on bolt-on acquisitions and returning capital to shareholders, pausing large-scale M&A after building key growth platforms. The recent increase in share repurchase authorization reflects this strategy shift.

Drivers of Future Performance

Management expects mixed end-market demand, continued cost discipline, and targeted growth investments to shape performance going into next year.

• Mixed industrial demand outlook: The company anticipates stability in core industrial markets but no near-term inflection, with order hesitancy and elongated decision cycles among large customers. Management will closely monitor “bellwether” businesses for signs of improvement or further slowdown.
• Margin expansion initiatives: Ongoing platform optimization, structural productivity gains, and cost containment efforts are expected to support margins. Management targets structural savings to carry into 2026, but notes some cost containment may be reversed if growth opportunities arise.
• Capital deployment priorities: With large M&A on pause, IDEX will focus on bolt-on deals to enhance existing platforms and return excess capital to shareholders through dividends and share repurchases, while maintaining financial flexibility.

Catalysts in Upcoming Quarters

In upcoming quarters, our analysts will focus on (1) the pace of organic growth in HST and municipal water platforms, (2) management’s ability to sustain margin improvements through ongoing cost initiatives, and (3) signs of stabilization or acceleration in industrial demand across bellwether businesses. Progress on bolt-on acquisitions and the execution of platform integrations will also be key indicators of future performance.

IDEX currently trades at $173.40, up from $166.95 just before the earnings. At this price, is it a buy or sell? The answer lies in our full research report (it’s free for active Edge members).

Stocks That Trumped Tariffs

When Trump unveiled his aggressive tariff plan in April 2025, markets tanked as investors feared a full-blown trade war. But those who panicked and sold missed the subsequent rebound that’s already erased most losses.

Don’t let fear keep you from great opportunities and take a look at Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.

StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.